These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. The prevalence of oestrogen replacement therapy in South Australia. MacLennan AH; MacLennan A; Wilson D Maturitas; 1993 May; 16(3):175-83. PubMed ID: 8515717 [TBL] [Abstract][Full Text] [Related]
26. Menopausal symptom management and prevention counseling after the Women's Health Initiative among women seen in an internal medicine practice. Schonberg MA; Wee CC J Womens Health (Larchmt); 2005; 14(6):507-14. PubMed ID: 16115005 [TBL] [Abstract][Full Text] [Related]
27. Perceptions of and attitudes toward estrogen therapy among surgically menopausal women in Taiwan. Chen RJ; Chang TC; Chow SN Menopause; 2008; 15(3):517-23. PubMed ID: 18188137 [TBL] [Abstract][Full Text] [Related]
28. Factors predicting current use of hormone replacement therapy among menopausal Jewish women in Israel. The National Women's Health Interview Survey, 1998. Merom D; Ifrah A; Cohen-Manheim I; Chinich A; Green MS Isr Med Assoc J; 2002 Sep; 4(9):671-6. PubMed ID: 12440227 [TBL] [Abstract][Full Text] [Related]
29. Important factors for use of hormone replacement therapy: a population-based study of Swedish women. The Women's Health in Lund Area (WHILA) Study. Li C; Samsioe G; Lidfelt J; Nerbrand C; Agardh CD; Menopause; 2000; 7(4):273-81. PubMed ID: 10914621 [TBL] [Abstract][Full Text] [Related]
30. Menopausal hormone therapy--benefits, adverse reactions, concerns and information sources in 2009. Tiihonen M; Saarela M; Saarinen S; Ahonen R; Heikkinen AM Maturitas; 2011 Sep; 70(1):69-73. PubMed ID: 21723053 [TBL] [Abstract][Full Text] [Related]
31. Long-term estrogen and hormone replacement therapy for the prevention and treatment of osteoporosis. Levine JP Curr Womens Health Rep; 2003 Jun; 3(3):181-6. PubMed ID: 12734027 [TBL] [Abstract][Full Text] [Related]
32. The Women's EMPOWER Survey: Women's Knowledge and Awareness of Treatment Options for Vulvar and Vaginal Atrophy Remains Inadequate. Krychman M; Graham S; Bernick B; Mirkin S; Kingsberg SA J Sex Med; 2017 Mar; 14(3):425-433. PubMed ID: 28202319 [TBL] [Abstract][Full Text] [Related]
33. Selection to postmenopausal therapy by women's characteristics. Hemminki E; Malin M; Topo P J Clin Epidemiol; 1993 Mar; 46(3):211-9. PubMed ID: 8455045 [TBL] [Abstract][Full Text] [Related]
35. Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women. Rodriguez C; Patel AV; Calle EE; Jacob EJ; Thun MJ JAMA; 2001 Mar; 285(11):1460-5. PubMed ID: 11255422 [TBL] [Abstract][Full Text] [Related]
36. Women's attitudes to hormone replacement therapy, alternative therapy and sexual health: a web-based survey. Cumming GP; Herald J; Moncur R; Currie H; Lee AJ Menopause Int; 2007 Jun; 13(2):79-83. PubMed ID: 17540139 [TBL] [Abstract][Full Text] [Related]
37. Does estrogen adequately protect postmenopausal women against osteoporosis: an iconoclastic perspective. Orwoll ES; Nelson HD J Clin Endocrinol Metab; 1999 Jun; 84(6):1872-4. PubMed ID: 10372678 [TBL] [Abstract][Full Text] [Related]
38. Timing of postmenopausal estrogen for optimal bone mineral density. The Rancho Bernardo Study. Schneider DL; Barrett-Connor EL; Morton DJ JAMA; 1997 Feb; 277(7):543-7. PubMed ID: 9032160 [TBL] [Abstract][Full Text] [Related]
39. Transdermal hormone therapy and the risk of stroke and venous thrombosis. Speroff L Climacteric; 2010 Oct; 13(5):429-32. PubMed ID: 20670199 [TBL] [Abstract][Full Text] [Related]
40. Hormone replacement therapy in general practice: a survey of doctors in the MRC's general practice research framework. Wilkes HC; Meade TW BMJ; 1991 Jun; 302(6788):1317-20. PubMed ID: 2059689 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]